Kadimastem Receives Patent for ItsCell Selection and Enrichment Technology Used to Develop Its IsletRx Treatment for Diabetes in India
–News Direct– Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company, developing and manufacturing "off-the-shelf" allogeneic cell products using...
